High dose vancomycin for osteomyelitis: continuous vs. intermittent infusion
Article Properties
-
LanguageEnglish
-
DOI (url)
-
Publication Date2004/08/01
-
Indian UGC (journal)
-
Refrences26
-
Citations82
-
A. Vuagnat
-
R. Stern
-
A. Lotthe
-
H. Schuhmacher
-
M. Duong
-
P. Hoffmeyer
-
L. Bernard
Cite
Vuagnat, A., et al. “High Dose Vancomycin for Osteomyelitis: Continuous Vs. Intermittent Infusion”. Journal of Clinical Pharmacy and Therapeutics, vol. 29, no. 4, 2004, pp. 351-7, https://doi.org/10.1111/j.1365-2710.2004.00572.x.
Vuagnat, A., Stern, R., Lotthe, A., Schuhmacher, H., Duong, M., Hoffmeyer, P., & Bernard, L. (2004). High dose vancomycin for osteomyelitis: continuous vs. intermittent infusion. Journal of Clinical Pharmacy and Therapeutics, 29(4), 351-357. https://doi.org/10.1111/j.1365-2710.2004.00572.x
Vuagnat A, Stern R, Lotthe A, Schuhmacher H, Duong M, Hoffmeyer P, et al. High dose vancomycin for osteomyelitis: continuous vs. intermittent infusion. Journal of Clinical Pharmacy and Therapeutics. 2004;29(4):351-7.
Journal Categories
Medicine
Public aspects of medicine
Toxicology
Poisons
Medicine
Therapeutics
Pharmacology
You May Also Like
- A Bayesian neural network method for adverse drug reaction signal generation
- Safety, pharmacodynamics, and pharmacokinetics of BAY 59-7939—an oral, direct Factor Xa inhibitor—after multiple dosing in healthy male subjects
- Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction
- Clinical consequences of polypharmacy in elderly
- Long-term side effects of glucocorticoids
Refrences
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
Effect of Vancomycin Therapy for Osteomyelitis on Colonization by Methicillin-ResistantStaphylococcus aureus: Lack of Emergence of Glycopeptide Resistance | Infection Control & Hospital Epidemiology |
| 17 | 2003 |
| 10.1128/JCM.36.4.1020-1027.1998 | 1998 | |||
| 10.1016/S0399-077X(97)80199-0 | 1997 | |||
| Efficacy and safety of vancomycin constant-rate infusion in the treatment of chronic Gram-positive bone and joint infections | Clinical Microbiology and Infection |
| 14 | 1997 |
| 10.1128/AAC.40.3.696 | 1996 |
Citations
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
| Determining steady-state trough range in vancomycin drug dosing using machine learning | Journal of Critical Care |
| 2024 | |
Patient safety outcomes for continuous infusion vancomycin as outpatient parenteral antimicrobial therapy | Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy |
| 2023 | |
A review of evidence, antimicrobial stability, and feasibility considerations for OPAT continuous infusion | Therapeutic Advances in Infectious Disease |
| 2023 | |
Pharmacokinetic/Pharmacodynamic Target Attainment of Vancomycin, at Three Reported Infusion Modes, for Methicillin-Resistant Staphylococcus aureus (MRSA) Bloodstream Infections in Critically Ill Patients: Focus on Novel Infusion Mode | Frontiers in Cellular and Infection Microbiology |
| 2022 | |
A Systematic Review on Clinical Safety and Efficacy of Vancomycin Loading Dose in Critically Ill Patients | Antibiotics |
| 6 | 2022 |
Citations Analysis
The category
Medicine: Therapeutics. Pharmacology 38
is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled Critical Issues in the Clinical Management of Complicated Intra-Abdominal Infections and was published in 2005. The most recent citation comes from a 2024 study titled Determining steady-state trough range in vancomycin drug dosing using machine learning. This article reached its peak citation in 2020, with 9 citations. It has been cited in 57 different journals, 24% of which are open access. Among related journals, the International Journal of Antimicrobial Agents cited this research the most, with 5 citations. The chart below illustrates the annual citation trends for this article.